ahlam1399
08-02-2016, 09:50 PM
Pfizer beats estimates, but branded ***** disappoint
(Reuters) – Pfizer Inc reported better-than-expected quarterly results, driven by lower taxes and sales of generic medicines, but revenue from its branded patent-protected medicines brought disappointment.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=wynERVgy2OY:zGjoVqrMwFs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wynERVgy2OY:zGjoVqrMwFs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=wynERVgy2OY:zGjoVqrMwFs:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wynERVgy2OY:zGjoVqrMwFs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=wynERVgy2OY:zGjoVqrMwFs:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/wynERVgy2OY
(Reuters) – Pfizer Inc reported better-than-expected quarterly results, driven by lower taxes and sales of generic medicines, but revenue from its branded patent-protected medicines brought disappointment.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=wynERVgy2OY:zGjoVqrMwFs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wynERVgy2OY:zGjoVqrMwFs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=wynERVgy2OY:zGjoVqrMwFs:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wynERVgy2OY:zGjoVqrMwFs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=wynERVgy2OY:zGjoVqrMwFs:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/wynERVgy2OY